Resultados de la búsqueda 141-150 of 10195 for Liver haemangioma

  1. Untitled

    Page 1.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The principal ...

  3. Enfermedad hepática del hígado graso no alcohólico - Etapas - Mayo Clinic

    American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The Patient Group 2 primary objectives are to assess the association of circulating and imaging biomarkers on Future Liver Remnant hypertrophy, and to assess ...

  5. Centro de Cáncer de Cabeza y Cuello - Ensayos clínicos - Mayo Clinic

    Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

  6. Enfermedad hepática del hígado graso no alcohólico - Médicos y departamentos - Mayo Clinic

    Liver Transplant Clinic · Pediatría · Programa de Cirugía Bariátrica en ... Snapshots of hope: Life on the other side of transplant. 110 Replies Sun, Nov 09, 2025.

  7. Oncología (médica) - Ensayos clínicos

    1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

  8. Hepatitis autoinmune - Síntomas y causas - Mayo Clinic

    Autoimmune hepatitis (AIH). American Liver Foundation. https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/autoimmune-hepatitis-aih/. Accessed ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    1. Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...